Clinical Trial Update: Use-Results Surveillance Study of Sovaldi® Plus Rebetol® in Japanese Patients With Chronic Genotype 2 Hepatitis C Virus Infection

View source ↗

Summary

A completed use-results surveillance study evaluating the combination of Sovaldi (sofosbuvir) plus Rebetol (ribavirin) in Japanese patients with chronic genotyp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Rebetol (ribavirin)
• Sovaldi (Sofosbuvir)

Snippet

Sponsor: Gilead Sciences | Conditions: Hepatitis C | Status: COMPLETED